Novo Nordisk Loses Challenge To Medicare Drug Price Talks
By Dan McKay · August 1, 2024, 5:39 PM EDT
Another challenge to a Medicare drug price negotiation program has failed after a New Jersey federal judge ruled once again that the program is voluntary and rejected claims that it violates...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login